Bluetongue - disease monograph series - 20
2016
Bluetongue (BT) is an infectious, non-contagious, vector-borne viral epizootic disease that affects domestic and wild ruminants. For target countries of the Livestock Vaccine Innovation Fund (LVIF), the economic and socio impacts are felt most in India and South Africa, but there is very limited information. It is difficult to make definitive statements about losses, due to concerns regarding differential diagnosis with common diseases. A BTV-8 outbreak in France (2007) was estimated to cost $1.4 billion. Treatment of BT-affected animals involves only nonspecific supportive and nursing care. Despite the major advances in understanding and prevention, a commercial recombinant vaccine against BT remains elusive.
显示更多 [+] 显示较少 [-]Bill & Melinda Gates Foundation
显示更多 [+] 显示较少 [-]Global Affairs Canada
显示更多 [+] 显示较少 [-]